Understanding Weight Loss Expectations with Mounjaro: How Much Weight Loss Per Week?

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide injection therapy activates two hormone pathways—GLP-1 and GIP—to regulate appetite and blood sugar simultaneously. Most patients experience measurable weight reduction within the first four weeks, though the pace varies significantly based on individual metabolism, adherence, and genetic factors that influence how your body responds to peptide signaling.

Weekly Weight Loss Rates with Tirzepatide Injections

Clinical data from tirzepatide trials shows an average loss of 0.5 to 2 pounds per week during active treatment, with the fastest losses typically occurring in months one through three. Patients starting at higher body weights often experience steeper initial declines—sometimes 3 to 5 pounds in the first two weeks—due to water loss and rapid appetite suppression. By month six, the rate often stabilizes to 0.5 to 1 pound weekly as your body reaches a lower metabolic baseline.

Weekly variability is completely normal and does not indicate treatment failure. Some weeks show no scale movement while your body reshapes internally; other weeks bring 2 to 3 pound drops. Hormonal cycles, sodium intake, sleep quality, and physical activity all influence week-to-week fluctuations, even when your medication dose remains constant.

How Tirzepatide Dosing Affects Your Weight Loss Timeline

Tirzepatide treatment begins at a low starting dose and increases gradually every four weeks until reaching your therapeutic dose. This stepped approach allows your body to adjust while minimizing nausea and side effects. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate starting at $289, regardless of whether you're on a starter dose or a higher maintenance level.

Higher maintenance doses (5 mg, 7.5 mg, 10 mg, or 15 mg weekly) typically produce greater cumulative weight loss by month six compared to lower doses, but the weekly rate difference is modest. Most patients reach plateau weight loss within three to six months on their optimal dose, meaning further reductions slow considerably unless lifestyle factors like exercise intensity increase.

Factors That Influence Your Personal Weight Loss Speed

Your starting weight, age, metabolism, and muscle mass directly affect how quickly tirzepatide works. Individuals with a higher initial BMI often lose weight faster in absolute pounds during the first three months compared to those starting closer to their goal weight. Metabolism naturally slows with age, so older patients may see slightly slower weekly losses than younger individuals on identical doses, though total six-month outcomes can still be substantial.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Realistic Monthly and Six-Month Weight Loss Expectations

Month one typically brings 2 to 5 pounds of loss as appetite drops and you naturally consume fewer calories. Months two and three often show the steepest curves, with cumulative losses of 8 to 20 pounds by the end of month three. By month six, most tirzepatide patients have lost between 15 and 35 pounds—roughly 5 to 10% of starting body weight—though individual ranges span much wider depending on genetic factors, adherence, and lifestyle changes.

Long-term sustainability matters more than weekly speed. Tirzepatide works best when combined with consistent nutrition and moderate activity—not because the medication requires it, but because these habits prevent weight regain once you stop treatment or reach your goal. Most patients find that tirzepatide makes adherence easier by reducing cravings and food noise, turning the behavioral side of weight loss into a less exhausting daily struggle.

Comparing Tirzepatide Results to Semaglutide and Microdose Protocols

Tirzepatide generally produces greater average weight loss than semaglutide alone because it activates both GLP-1 and GIP hormone pathways, whereas semaglutide targets only GLP-1. Clinical trials show tirzepatide users lose approximately 20% of body weight by six months compared to 15% for semaglutide at comparable treatment duration. For patients seeking maximum results, PlexusDx's Tirzepatide Injection ($289/month) or oral formulation ($349/month) offer stronger pathway engagement than single-agent approaches.

For individuals who prefer gentler initial effects or experience significant nausea on standard doses, PlexusDx's Microdose GLP-1 Protocol ($129/month) provides a lower-dose entry point with more gradual weekly losses—typically 0.25 to 0.75 pounds weekly initially. This option suits patients with medication sensitivity or those using tirzepatide alongside other treatments where drug interaction requires cautious dosing.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I lose in my first month on tirzepatide?

Most patients lose 2 to 5 pounds in month one as appetite hormones shift and calorie intake naturally drops. Expect the fastest losses in months two and three, then gradual stabilization by month six. Your individual timeline depends on your starting weight, metabolism, and genetic peptide-response profile.

Why is my weekly weight loss slower than someone else on the same tirzepatide dose?

Genetic variants in the GLP1R, GIPR, and FTO genes influence how effectively tirzepatide suppresses appetite and affects your metabolism. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first treatment month) reveals these individual predispositions, explaining why two patients on identical doses experience different weekly results.

Is tirzepatide injection more effective than oral tirzepatide for weekly weight loss?

Tirzepatide injection ($289/month) and oral tirzepatide ($349/month) produce similar weekly weight loss rates and six-month outcomes when properly dosed. Injection formulations absorb predictably through subcutaneous tissue, while oral absorption varies with stomach pH and food content. Choose based on your preference for injection frequency versus daily oral dosing—both deliver equivalent therapeutic results.

What if I'm not losing weight every single week?

Week-to-week weight plateaus are completely normal and don't indicate treatment failure. Body composition changes, hormonal cycles, water retention, and sodium intake all cause scale variability. Focus on monthly trends and how your clothes fit rather than daily or weekly fluctuations. Most patients see consistent downward momentum when tracking weight every two to four weeks instead.

Does PlexusDx charge more if I need a higher tirzepatide dose for faster weight loss?

No. PlexusDx charges a flat monthly rate of $289 for Tirzepatide Injection or $349 for oral tirzepatide, regardless of your dose level. Your dose may need to go up. Your price won't. This pricing structure applies across all three commitment tiers, ensuring transparent, predictable costs whether you're on a starter or maintenance dose.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro Weight Loss By Week
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.